LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Elevance Health Inc

Elevance Health Inc

Suletud

Sektor Tervishoid

542.93 -0.16

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

542.31

Max

544.81

Põhinäitajad
By Trading Economics
Sissetulek	54M 2.3B
Müük	920M 43B
P/E Sektori keskmine	20.44 103.001
Aktsiakasum	10.12
Kasumimarginaal	5.322
Töötajad	104,900

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+10.9 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	16. okt 2024
Järgmine dividendimakse kuupäev	25. sept 2024
Järgmine aktsia dividendi kuupäev (ex-date)	10. sept 2024

Turustatistika
By TradingEconomics
Turukapital	130B
Eelmine avamishind	543.09
Eelmine sulgemishind	542.93

Uudiste sentiment

By Acuity

64%

36%

83 / 365 Pingereas Healthcare

Elevance Health Inc Graafik

Seotud uudised

18. apr 2024, 10:47 UTC

Tulu

Elevance Health 1Q Revenue Rises, Membership Keeps Declining; Raises Guidance

18. märts 2024, 20:48 UTC

Omandamised, ülevõtmised, äriostud

Kroger to Sell Specialty Pharmacy Business -- Update

18. märts 2024, 20:34 UTC

Omandamised, ülevõtmised, äriostud

Kroger to Sell Specialty Pharmacy Business

24. jaan 2024, 11:32 UTC

Tulu

Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains

25. juuli 2024, 11:00 UTC

Peamised uudised

Medicaid Was a Boon to Insurers During the Pandemic. Now, Not So Much. -- Heard on the Street -- WSJ

17. juuli 2024, 10:38 UTC

Tulu

Elevance Health Stock Rises After Earnings Beat Forecasts -- WSJ

17. juuli 2024, 10:00 UTC

Tulu

Elevance Health 2Q Rev $43.89B >ELV

17. juuli 2024, 10:00 UTC

Tulu

Elevance Health 2Q Benefit Expense Ratio 86.3% >ELV

17. juuli 2024, 10:00 UTC

Tulu

Elevance Health 2Q Net $2.3B >ELV

17. juuli 2024, 10:00 UTC

Tulu

Elevance Health 2Q Adj EPS $10.12 >ELV

17. juuli 2024, 10:00 UTC

Tulu

Elevance Health 2Q EPS $9.85 >ELV

17. juuli 2024, 10:00 UTC

Tulu

Elevance Health 2Q Medical Enrollment Members 45.8M >ELV

14. juuli 2024, 22:41 UTC

Tulu

Stocks Poised for Higher Open -- Barrons.com

13. juuni 2024, 18:51 UTC

Peamised uudised

Medicare Will Recalculate Quality Ratings of Medicare Advantage Plans -- WSJ

22. apr 2024, 11:00 UTC

Peamised uudised

Tulu

Insurer Earnings Make Hospital Investors Sweat -- Heard on the Street -- WSJ

18. apr 2024, 10:03 UTC

Tulu

Elevance Health Declares 2Q Dividend of $1.63>ELV

18. apr 2024, 10:00 UTC

Tulu

Elevance Health 1Q Rev $42.58B >ELV

18. apr 2024, 10:00 UTC

Tulu

Elevance Health 1Q Medical Enrollment Members 46.2M >ELV

18. apr 2024, 10:00 UTC

Tulu

Elevance Health 1Q Net $2.25B >ELV

18. apr 2024, 10:00 UTC

Tulu

Elevance Health 1Q Benefit Expense Ratio 85.6% >ELV

18. apr 2024, 10:00 UTC

Tulu

Elevance Health 1Q Adj EPS $10.64 >ELV

18. apr 2024, 10:00 UTC

Tulu

Elevance Health 1Q EPS $9.59 >ELV

28. märts 2024, 13:07 UTC

Peamised uudised

First Medicare Health Plans to Start Paying for Weight-Loss Drug Wegovy -- WSJ

19. märts 2024, 09:33 UTC

Kuumad aktsiad

Stocks to Watch Tuesday: Unilever, Fusion Pharmaceuticals, Tesla -- WSJ

18. märts 2024, 22:23 UTC

Omandamised, ülevõtmised, äriostud

Kroger to Sell Specialty Pharmacy Business -- 2nd Update

18. märts 2024, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Kroger: Transaction Not Expected to Have an Impact on Kroger's 2024 Guidance >KR

18. märts 2024, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Kroger: Selling Specialty Pharmacy Business to CarelonRx, a Subsidiary of Elevance Health >KR

25. jaan 2024, 16:06 UTC

Tulu

Humana Stock Sinks After Surprise Loss and Grim Outlook. Blame Medicare Advantage. -- Barrons.com

25. jaan 2024, 15:06 UTC

Peamised uudised

It Is Going to Be a Bad Year (or More) for the Medicare Business -- Heard on the Street -- WSJ

24. jaan 2024, 11:06 UTC

Tulu

Elevance Health 4Q Operating Expense Ratio 11.8% >ELV

Võrdlus sarnastega

Hinnamuutus

Elevance Health Inc Prognoos

Hinnasiht

By TipRanks

10.9% tõus

12 kuu keskmine prognoos

Keskmine 603.73 USD 10.9%

Kõrge 655 USD

Madal 530 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Elevance Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

Osta

Hoia

Müü

Põhineb 13 analüütiku instrumendi Elevance Health Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

83 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Elevance Health Inc

Anthem, Inc. is a health benefits company. The Company operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.